Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 55, Issue 4, Pages 1030-1037
Publisher
Wiley
Online
2011-11-17
DOI
10.1002/hep.24788
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: Implications for treatment duration
- (2011) Jeremie Guedj et al. HEPATOLOGY
- Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir in genotype 1-infected patients
- (2011) Frank Wagner et al. HEPATOLOGY
- Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus
- (2011) Jean-Michel Pawlotsky HEPATOLOGY
- 1359 FIRST SVR DATA WITH THE NUCLEOSIDE ANALOGUE POLYMERASE INHIBITOR MERICITABINE (RG7128) COMBINED WITH PEGINTERFERON/RIBAVIRIN IN TREATMENT-NAIVE HCV G1/4 PATIENTS: INTERIM ANALYSIS FROM THE JUMP-C TRIAL
- (2011) P. Pockros et al. JOURNAL OF HEPATOLOGY
- 1201 NEW INSIGHTS INTO THE MECHANISM OF ACTION OF INTERFERON-ALPHA AND BMS-790052: A MULTI-SCALE MATHEMATICAL MODELING APPROACH
- (2011) H. Dahari et al. JOURNAL OF HEPATOLOGY
- 455 HCV VIRAL KINETICS DURING RIBAVIRIN MONOTHERAPY: RESULTS OF A RANDOMIZED PARTIALLY DOUBLE BLIND PLACEBO CONTROLLED CLINICAL TRIAL
- (2011) U. Mihm et al. JOURNAL OF HEPATOLOGY
- 1370 ONCE DAILY DUAL-NUCLEOTIDE COMBINATION OF PSI-938 AND PSI-7977 PROVIDES 94% HCVRNA
- (2011) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis
- (2010) Ana-Carolina Cardoso et al. JOURNAL OF HEPATOLOGY
- RG7128 Alone or in Combination with Pegylated Interferon‐α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV‐Infected Patients
- (2010) Sophie Le Pogam et al. JOURNAL OF INFECTIOUS DISEASES
- Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics
- (2010) J. Guedj et al. JOURNAL OF THEORETICAL BIOLOGY
- A perspective on modelling hepatitis C virus infection
- (2010) J. Guedj et al. JOURNAL OF VIRAL HEPATITIS
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Mathematical Model of Hepatitis C Virus Dynamics in Patients With High Baseline Viral Loads or Advanced Liver Disease
- (2009) Harel Dahari et al. GASTROENTEROLOGY
- Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials
- (2009) Tahany Awad et al. HEPATOLOGY
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now